Pharmaceutical - Novo Nordisk, Financial

Filter

Current filters:

Novo NordiskFinancial

Popular Filters

1 to 25 of 28 results

Novo Nordisk beats estimates as net profit grows 4%

Novo Nordisk beats estimates as net profit grows 4%

07-08-2014

Danish diabetes care giant Novo Nordisk released first-half 2014 financial results this morning, showing…

Business FinanceChief executiveDiabetesFinancialNOKNovo NordiskPeptide hormonesPharmaceuticalRecombinant proteins

Quebec first province to add Victoza to the drug benefit formulary

Quebec first province to add Victoza to the drug benefit formulary

04-06-2014

The Canadian subsidiary of Danish diabetes care giant Novo Nordisk says that the Quebec government has…

CanadaDiabetesFinancialHealthcareNovo NordiskPharmaceuticalVictoza

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

14-03-2014

Danish insulin giant Novo Nordisk revealed this morning that it is increasing its drug development capacity…

DiabetesFinancialNovo NordiskPharmaceuticalProduction

Five big pharma firms named as high performers in annual biopharmaceutical report

Five big pharma firms named as high performers in annual biopharmaceutical report

12-02-2014

Entry in emerging markets and expedient product launches are still driving the pharma market, according…

AmgenAstellas PharmaBristol-Myers SquibbFinancialMarkets & MarketingNovo NordiskPharmaceuticalResearchRoche

Novo Nordisk’s profits rise 15% with further growth expected

Novo Nordisk’s profits rise 15% with further growth expected

30-01-2014

Danish insulin giant Novo Nordisk has announced a 15% growth in profit in the firm’s 2013 financial…

DenmarkDiabetesFinancialNovo NordiskPharmaceuticalTresibaVictoza

Novo Nordisk and Sanofi best positioned in diabetes market, says Morningstar

Novo Nordisk and Sanofi best positioned in diabetes market, says Morningstar

10-12-2013

Demographics favor the continued strong growth in the diabetes care market, and independent investment…

DiabetesEli LillyFinancialMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Novo Nordisk accused of delaying information release under Danish STC rules

Novo Nordisk accused of delaying information release under Danish STC rules

10-12-2013

Danish insulin giant Novo Nordisk revealed this morning that the Danish Financial Supervisory Authority…

DenmarkDiabetesEuropeFinancialLegalNovo NordiskPharmaceuticalRyzodegTresiba

Novo Nordisk nine-month sales up 13%; takes larger diabetes market share

Novo Nordisk nine-month sales up 13%; takes larger diabetes market share

31-10-2013

Danish insulin giant Novo Nordisk reported sales of 61.9 billion ($11.3 billion) Danish kroner in the…

DiabetesFinancialNovo NordiskPharmaceutical

Geropharm to invest $45 million in Russian insulin production

Geropharm to invest $45 million in Russian insulin production

25-09-2013

Geropharm, one of Russia’s leading pharmaceutical and biotech companies, is establishing a plant for…

DiabetesEli LillyEuropeFinancialGeropharmNovo NordiskPharmaceuticalProductionSanofi

Novo Nordisk first-half boosted by Victoza and modern insulins

08-08-2013

Danish insulin giant Novo Nordisk (NOV: N) posted second quarter 2013, showing that earnings before interest…

DiabetesFinancialNovo NordiskPharmaceutical

Strong first-quarter growth from Novo Nordisk and Lundbeck

01-05-2013

This morning saw the announcement of first-quarter 2013 financial results from Denmark's two leading…

FinancialLundbeckNovo NordiskPharmaceutical

Briefs: Elan tender offer; German drug price review; Daiichi Sankyo pays milestone

19-04-2013

Ireland-based drugmaker Elan (NYSE: ELN) yesterday reported final results of its modified Dutch auction…

ActemraAmgenAnticalinBayerElanFinancialNovo NordiskPharmaceuticalPradaxaPricingProliaRegulationResearchRocheVictozaXarelto

Novo Nordisk 2012 net profit leaps 25% and sales rise 18%

31-01-2013

Denmark-based insulin giant Novo Nordisk (NOV: N) saw its shares rise 1.6% to 1,037 kroner in early trading…

FinancialNovo NordiskPharmaceutical

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus

20-12-2012

Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

Russia's Renova invests in Novelos; Novo Nordisk opens Vietnam office

08-11-2012

USA-based Novelos Therapeutics (OTCQX: NVLT), which is developing novel drugs for the treatment and diagnosis…

Asia-PacificDiabetesFinancialMarkets & MarketingNovelos TherapeuticsNovo NordiskOncologyPharmaceutical

Novo Nordisk net profit leaps 26% in first nine months of 2012

31-10-2012

Danish insulin giant Novo Nordisk (NOV: N) today reported financial results for the first nine months…

DiabetesFinancialNovo NordiskPharmaceutical

Novo Nordisk invests $100 million for bigger R&D center in China

24-09-2012

Denmark's Novo Nordisk (NOV: N) said this morning that it is investing an additional $100 million to…

Asia-PacificFinancialNovo NordiskPharmaceuticalResearch

Novo Nordisk ups forecast on strong diabetes drug sales

09-08-2012

Denmark's Novo Nordisk, the world's largest insulin producer, this morning posted financial results for…

DiabetesFinancialNovo NordiskPharmaceuticalResearch

Novo Nordisk and AstraZeneca among firms to invest in Russian pharma hub

11-07-2012

In Russia, the Kaluga government plans to establish a pharmaceutical manufacturing hub in the region…

AstraZenecaEuropeFinancialMarkets & MarketingMenariniNovo NordiskPharmaceuticalSTADA Arzneimittel

Novo Nordisk starts year with 15% net profits hike

30-04-2012

Danish insulin giant Novo Nordisk (NOV: N) reported first-quarter 2012 results last Friday, with a 13%…

DegludecDiabetesFinancialNovo NordiskPharmaceuticalRyzodegTresiba

Ground-breaking on new Novo Nordisk plant in Russia

17-04-2012

Danish insulin giant Novo Nordisk (NOV: N) broke ground yesterday on a new $100 million plant in Russia…

EuropeFinancialInsulinMarkets & MarketingNovo NordiskPharmaceutical

Victoza sales boost Novo Nordisk

03-02-2012

Danish insulin giant Novo Nordisk (NVO: N) yesterday reported full-year 2011 sales of 66.35 billion Danish…

DiabetesFinancialNovo NordiskPharmaceuticalVictoza

1 to 25 of 28 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top